12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several healthcare stocks experienced significant movements. Exicure (XCUR) saw a 54.5% increase, while Avid Bioservices (CDMO) dropped 22.5% following their Q2 earnings release. Other notable gainers included Aligos Therapeutics (ALGS), Tonix Pharmaceuticals (TNXP), Reshape Lifesciences (RSLS), Tharimmune (THAR), and Adial Pharmaceuticals (ADIL). Conversely, Processa Pharma (PCSA), Solid Biosciences (SLDB), Modular Medical (MODD), 89bio (ETNB), and Senti Biosciences (SNTI) were among the losers.
December 07, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adial Pharmaceuticals' stock went up by 6.34% to $2.18, with a market cap of $2.6 million.
The increase in Adial Pharmaceuticals' stock price may lead to a short-term positive impact as it may draw investor interest.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Aligos Therapeutics' stock increased by 33.84% to $0.87, with a market cap of $65.1 million.
Aligos Therapeutics' significant stock price rise could lead to continued investor interest and a short-term positive impact on the stock.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Reshape Lifesciences' stock increased by 7.31% to $0.28, with a market cap of $3.6 million.
The positive movement in Reshape Lifesciences' stock could suggest a short-term upward trend in its stock price.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Tharimmune's stock price rose by 7.26% to $0.65, with a market cap of $1.6 million.
Tharimmune's stock price increase could potentially lead to a short-term positive impact due to investor optimism.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Tonix Pharmaceuticals saw a 7.86% increase in stock price to $0.41, with a market cap of $9.7 million.
The rise in Tonix Pharmaceuticals' stock price may have a positive short-term impact due to increased investor attention.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Exicure's stock rose significantly by 54.5% to $0.66, with a market cap of $5.7 million.
The substantial increase in Exicure's stock price could attract investor interest, potentially leading to a short-term positive impact on the stock.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Avid Bioservices shares fell by 22.5% to $4.1, with a market cap of $258.7 million, following their Q2 earnings release.
The decline in Avid Bioservices' stock price following their Q2 earnings suggests a negative market reaction that could lead to a short-term negative impact on the stock.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100